Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Hallberg

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Organic & Biomolecular Chemistry|August 4, 2006
Variations of the P2 group in HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffoldJenny K Ekegren, Johan Gising, Hans Wallberg, et al.
Bioorganic & Medicinal Chemistry|June 6, 2003
Effect of 3-5 monocyclizations of angiotensin II and 4-aminoPhe6-Ang II on AT2 receptor affinitySusanna Lindman, Gunnar Lindeberg, Per-Anders Frändberg, et al.
The Journal of Organic Chemistry|August 16, 2003
A new regioselective Heck vinylation with enamides. Synthesis and investigation of fluorous-tagged bidentate ligands for fast separationKarl S A Vallin, Qisheng Zhang, Mats Larhed, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and IIAnders Dahlgren, Ingemar Kvarnström, Lotta Vrang, et al.
Journal of Medicinal Chemistry|February 6, 2004
A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin IIUlrika Rosenström, Christian Sköld, Gunnar Lindeberg, et al.
Biomolecules|April 29, 2020
Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor AgonistsSilvana Vasile, Anders Hallberg, Jessica Sallander, et al.
Bioorganic & Medicinal Chemistry|August 7, 2003
C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictionsKarolina Ersmark, Isabella Feierberg, Sinisa Bjelic, et al.
Journal of Combinatorial Chemistry|July 12, 2005
High-speed synthesis of potent C2-symmetric HIV-1 protease inhibitors by in-situ aminocarbonylationsJohan Wannberg, Nils-Fredrik K Kaiser, Lotta Vrang, et al.
Journal of Medicinal Chemistry|February 21, 2003
Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytesDaniel Nöteberg, Elizabeth Hamelink, Johan Hultén, et al.
Journal of Medicinal Chemistry|September 29, 2006
Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptorsUlrika Rosenström, Christian Sköld, Gunnar Lindeberg, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Organic & Biomolecular Chemistry|August 4, 2006
Variations of the P2 group in HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffoldJenny K Ekegren, Johan Gising, Hans Wallberg, et al.
Bioorganic & Medicinal Chemistry|June 6, 2003
Effect of 3-5 monocyclizations of angiotensin II and 4-aminoPhe6-Ang II on AT2 receptor affinitySusanna Lindman, Gunnar Lindeberg, Per-Anders Frändberg, et al.
The Journal of Organic Chemistry|August 16, 2003
A new regioselective Heck vinylation with enamides. Synthesis and investigation of fluorous-tagged bidentate ligands for fast separationKarl S A Vallin, Qisheng Zhang, Mats Larhed, et al.
Bioorganic & Medicinal Chemistry|March 5, 2003
Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and IIAnders Dahlgren, Ingemar Kvarnström, Lotta Vrang, et al.
Journal of Medicinal Chemistry|February 6, 2004
A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin IIUlrika Rosenström, Christian Sköld, Gunnar Lindeberg, et al.
Biomolecules|April 29, 2020
Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor AgonistsSilvana Vasile, Anders Hallberg, Jessica Sallander, et al.
Bioorganic & Medicinal Chemistry|August 7, 2003
C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictionsKarolina Ersmark, Isabella Feierberg, Sinisa Bjelic, et al.
Journal of Combinatorial Chemistry|July 12, 2005
High-speed synthesis of potent C2-symmetric HIV-1 protease inhibitors by in-situ aminocarbonylationsJohan Wannberg, Nils-Fredrik K Kaiser, Lotta Vrang, et al.
Journal of Medicinal Chemistry|February 21, 2003
Design and synthesis of plasmepsin I and plasmepsin II inhibitors with activity in Plasmodium falciparum-infected cultured human erythrocytesDaniel Nöteberg, Elizabeth Hamelink, Johan Hultén, et al.
Journal of Medicinal Chemistry|September 29, 2006
Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptorsUlrika Rosenström, Christian Sköld, Gunnar Lindeberg, et al.
Pageof 11